U.S. Markets open in 4 hrs 13 mins

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
651.88-1.30 (-0.20%)
At close: 4:00PM EDT
642.00 -9.88 (-1.52%)
Pre-Market: 04:54AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3686.62
52 Week Low 3441.00
50-Day Moving Average 3642.86
200-Day Moving Average 3546.64

Share Statistics

Avg Vol (3 month) 3777.5k
Avg Vol (10 day) 3722.02k
Shares Outstanding 5104.69M
Implied Shares Outstanding 6N/A
Float 98.65M
% Held by Insiders 12.96%
% Held by Institutions 190.56%
Shares Short (Jun 14, 2021) 41.92M
Short Ratio (Jun 14, 2021) 42.79
Short % of Float (Jun 14, 2021) 42.17%
Short % of Shares Outstanding (Jun 14, 2021) 41.80%
Shares Short (prior month May 13, 2021) 42.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 44.43%
Operating Margin (ttm)41.14%

Management Effectiveness

Return on Assets (ttm)13.82%
Return on Equity (ttm)33.21%

Income Statement

Revenue (ttm)9.01B
Revenue Per Share (ttm)84.61
Quarterly Revenue Growth (yoy)38.30%
Gross Profit (ttm)4.46B
Net Income Avi to Common (ttm)4B
Diluted EPS (ttm)35.13
Quarterly Earnings Growth (yoy)78.50%

Balance Sheet

Total Cash (mrq)3.5B
Total Cash Per Share (mrq)33.83
Total Debt (mrq)2.7B
Total Debt/Equity (mrq)22.52
Current Ratio (mrq)3.12
Book Value Per Share (mrq)115.54

Cash Flow Statement

Operating Cash Flow (ttm)2.59B
Levered Free Cash Flow (ttm)955.01M